Search

Home > Lung Cancer Considered > FDA Approval: Maintenance Lurbinectedin for SCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Maintenance Lurbinectedin for SCLC
Category: Science & Medicine
Duration: 00:37:53
Publish Date: 2025-10-07 13:00:03
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC. Guest: Dr. Hossein Borghaei, DO, MS Chief, Division of Thoracic Medical Oncology Professor, Department of Hematology/Oncology Fox Chase Cancer Center
Total Play: 0